New Research into Antipsychotic Discontinuation And Reduction: the RADAR programme

The UK government’s National Institute of Health Research (NIHR) has recently agreed to fund a new study to compare a gradual and supported programme of antipsychotic reduction with maintenance treatment. The RADAR research programme (Research into Antipsychotic Discontinuation And Reduction) has just started.

Moncrieff is known to be strongly anti/critical of the use of medication.

The https link was faulty. This one works better.

For me personally, it would dangerous and irresponsible. But no doubt someone will benefit from the program.

I think it’s a good idea for people who are not benefiting from their APs and need help tapering off of them. Not everyone benefits from APs, and there is not much point in suffering the side effects if the medication isn’t even helping you. Hopefully they are able to take care in determining the difference between a candidate who is not benefiting, and a candidate who does not realize they are benefiting.

I have already reduced my Risperdal dose a bit, from 2.5 mg down to 2.25 mg.

Eventually I will go as low as possible, so far no Mania or Hallucinations, etc…

Im reducing it because of the possibility of a Pituatary Tumor.

Hopefully I will be able to tolerate the reduction.

My pdoc is on board.

It would be better to do something fatal to a person, but oh wait. It is fatal to our brains. Anti med people are essentially zombies.

@Wave I’m sorry about your possible tumor. I hope you can get it removed safely if you have one.

1 Like